Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2025 Earnings Conference Call May 8, 2025 2:00 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President and Chief Executive Officer Conference Call Participants Ben Klee - Lake Street Operator Hello, and welcome to Arcadia Biosciences First Quarter 2025 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript
Arcadia Biosciences, Inc (NASDAQ:RKDA ) Q4 2024 Results Conference Call March 20, 2025 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder.
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.
Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Operator Good afternoon, and welcome to Arcadia Biosciences Third Quarter 2024 Financial Results and Business Highlights Conference Call.
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences, Inc. (RKDA) Q2 2024 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Mark Kawakami - CFO T.J. Schaefer - President & CEO Conference Call Participants Raghuram Selvaraju - H.C.
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.
Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat
Arcadia Biosciences' (RKDA) Q1 results benefit from a decline in operating expenses.
